LMR 6

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

magnesium a ? color in a flame

blue

Reliable index of intestinal carbohydrate absorption:

D-XYLOSE

Condensation of glucose with aromatic amine in hot glacial acetic acid solution to produce a green-colored product:

O-TOLUIDINE

Condensation of glucose with aromatic amine in hot glacial acetic acid solution to produce a ?-colored product: O-TOLUIDINE

green

REFERENCE METHOD for glucose:

HEXOKINASE

REFERENCE METHOD for ?: HEXOKINASE

glucose

Split in the albumin band:

BISALBUMINEMIA

Compound normally found in urine that may be used to assess the completeness of a 24-hour urine collection:

CREATININE

: CK then AST then LD

Myocardial infarction

Myocardial infarction: (3)

CK then AST then LD

Specimen of choice for analysis of acid-base disturbances:

ARTERIAL BLOOD

Anticoagulant of choice for blood gas analysis:

HEPARIN

Symptom of HYPOCALCEMIA:

TETANY

Symptom of ?: TETANY

HYPOCALCEMIA

Calcium and phosphate metabolism is regulated by the:

PARATHYROID

? and ? metabolism is regulated by the: PARATHYROID

Calcium and phosphate

In the blood, bicarbonate leaves the RBCs and enters the plasma through an exchange mechanism with:

CHLORIDE

Major mineralocorticoid:

ALDOSTERONE

Adrenal medulla secretes this hormone in the greatest quantity:

EPINEPHRINE

? secretes this hormone in the greatest quantity: EPINEPHRINE

Adrenal medulla

Hollander insulin test is used to confirm:

VAGOTOMY

? test is used to confirm: VAGOTOMY

Hollander insulin test

Most potent estrogen:

ESTRADIOL

Assay to monitor the fetoplacental unit:

ESTRIOL

Hormone associated with galactorrhea, pituitary adenoma, and amenorrhea:

PROLACTIN

Hormone associated with ?, ?, and ?: PROLACTIN

galactorrhea, pituitary adenoma, and amenorrhea

Zollinger-Ellison syndrome is characterized by elevation of:

GASTRIN

Conn’s disease: ? caused by adrenal adenoma, carcinoma or hyperplasia

PRIMARY HYPERALDOSTERONISM

? disease: PRIMARY HYPERALDOSTERONISM caused by adrenal adenoma, carcinoma or hyperplasia

Conn’s disease

? disease: PRIMARY HYPERALDOSTERONISM caused by ?, ? or ?

adrenal adenoma, carcinoma or hyperplasia

Increased 5-HIAA: ?, carcinoid tumor composed of argentaffin cells. Carcinoid tumors are usually found in the intestine or lung

ARGENTAFFINOMA

Increased 5-HIAA: ARGENTAFFINOMA, carcinoid tumor composed of argentaffin cells. ? are usually found in the intestine or lung

Carcinoid tumor

Increased ?: ARGENTAFFINOMA, carcinoid tumor composed of argentaffin cells. Carcinoid tumors are usually found in the intestine or lung

5-HIAA

Thyroid hormones are derived from the amino acid:

TYROSINE

? are derived from the amino acid: TYROSINE

Thyroid hormones

Pharmacological parameters that determine serum drug concentration: ?

liberation, absorption, distribution, metabolism and excretion (LADME)

Route of drug administration associated with 100% bioavailability:

INTRAVENOUS

TRINDER REACTION:

SALICYLATE

? REACTION: SALICYLATE

TRINDER REACTION

Acetaminophen (paracetamol) is particularly toxic to the ?

LIVER

is particularly toxic to the

Acetaminophen (paracetamol)

Increased trough levels of AMINOGLYCOSIDES in the serum are often associated with toxic effects to the ?

KIDNEY

Increased trough levels of ? in the serum are often associated with toxic effects to the KIDNEY

AMINOGLYCOSIDES

: NEPHROTOXIC (toxic to KIDNEYS) and OTOTOXIC (EARS)

Aminoglycoside

Aminoglycoside: ? (toxic to KIDNEYS) and OTOTOXIC (EARS)

NEPHROTOXIC

Aminoglycoside: NEPHROTOXIC (toxic to KIDNEYS) and ? (EARS)

OTOTOXIC

Specimen appropriate for determining exposure to lead:

WHOLE BLOOD

? is synthesized from MORPHINE

HEROIN

HEROIN is synthesized from ?

MORPHINE

? is the principal active component of MARIJUANA

TETRAHYDROCANNABINOL (THC)

TETRAHYDROCANNABINOL (THC) is the principal active component of ?

MARIJUANA

ODOR OF BITTER ALMONDS:

CYANIDE POISONING

ODOR OF ?: CYANIDE POISONING

BITTER ALMONDS

Garlic on breath, metallic taste on mouth. ? HAS HIGH AFFINITY TO KERATIN

ARSENIC

? on breath, metallic taste on mouth. ARSENIC HAS HIGH AFFINITY TO KERATIN

Garlic

Garlic on breath, ? taste on mouth. ARSENIC HAS HIGH AFFINITY TO KERATIN

metallic

Garlic on breath, metallic taste on mouth. ARSENIC HAS HIGH AFFINITY TO ?

KERATIN

Analysis of urine, hair, and nails, using ion emission spectroscopy, is important for the diagnosis of ?

chronic ARSENIC poisoning

Analysis of urine, hair, and nails, using ?, is important for the diagnosis of chronic ARSENIC poisoning

ion emission spectroscopy

Total renal BLOOD flow:

1,200 mL/min

Total renal PLASMA flow:

600 to 700 mL/min

? serves as nonselective filter of plasma substances with MW of less than 70,000 daltons

Glomerulus

Glomerulus serves as nonselective filter of plasma substances with MW of less than ? daltons

70,000

Serum osmolarity:

275 to 300 mOsm

? osmolarity: 275 to 300 mOsm

Serum osmolarity

Urine osmolarity range:

50 and 1,400 mOsm

? osmolarity range: 50 and 1,400 mOsm

Urine

Normal person excretes approximately ? of acid in the form of titratable acid (H+) or ammonium ions (NH4+)

70 mEq/day

Urine volume range ? in 24 hours

600 to 2,000 mL

Urine volume average ? in 24 hours

1,200 to 1,500 mL

Normal random urine pH: pH ?

4.5 to 8

First morning urine pH:

5 to 6

1 g/dL protein, raise urine specific gravity by refractometer or urinometer by

0.003

1 g/dL glucose, raise urine specific gravity by refractometer or urinometer by

0.004

. Calibration of refractometer using distilled water:

1.000

Calibration of refractometer using 5% NaCl:

1.022 ± 0.00

Calibration of refractometer using ?% NaCl: 1.022 ± 0.00

Calibration of refractometer using 9% Sucrose:

1.034 ± 0.001

Calibration of refractometer using ?% Sucrose: 1.034 ± 0.001

Urine protein: less than ? 24 hours (Henry less than 150mg/24 hours)

10 mg/dL or 100 mg/

Urine protein: less than 10 mg/dL or 100 mg/24 hours (Henry less than ?/24 hours)

150mg

?: less than 10 mg/dL or 100 mg/24 hours (Henry less than 150mg/24 hours)

Urine protein

Significant AER: ?min or 30 to 300 mg albumin/24 hours

20 to 200 ug/min

Significant AER: 20 to 200 ug/min or ? mg albumin/24 hours

30 to 300 mg albumin

Renal threshold for glucose is

160 to 180 mg/dL

: 78% BHA, 20% AAA and 2% Acetone

Ketones

Ketones: ?% BHA, 20% AAA and 2% Acetone

Ketones: 78% BHA, ?% AAA and 2% Acetone

Ketones: 78% BHA, 20% AAA and ?% Acetone

Ketones: 78% ?, 20% AAA and 2% Acetone

BHA

Ketones: 78% BHA, 20% ? and 2% Acetone

AAA

Ketones: 78% BHA, 20% AAA and 2% ?

Acetone

Concentration of myoglobin must be at least ?before a red pigmentation can be visualized

25 mg/dL

Concentration of ? must be at least 25 mg/dL before a red pigmentation can be visualized

myoglobin

Concentration of myoglobin must be at least 25 mg/dL before a COLOR? pigmentation can be visualized

RED

Ehrlich’s units (EU) are EQUAL to

mg/dL

Normal values for the Addis count: 0 to 500,000

RBCs

Normal values for the Addis count: RBCs

0 to 500,000

Normal values for the Addis count: WBCs & epithelial cells

0 to 1,800,000

100

Normal values for the Addis count: 0 to 1,800,000

WBCs & epithelial cells

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前